| 前收市價 | 0.1000 |
| 開市 | 0.1000 |
| 買盤 | 0.0000 |
| 賣出價 | 2.2500 |
| 拍板 | 45.00 |
| 到期日 | 2025-01-17 |
| 今日波幅 | 0.1000 - 0.1000 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 421 |
BenzingaIndian Rival Meril Accuses Edwards Lifesciences Of Anti-Competitive Behavior In EU Antitrust Complaint
On Monday, U.S. heart valve manufacturer Edwards Lifesciences Corporation (NYSE:EW) faced an EU antitrust complaint from Indian competitor Meril, alleging anti-competitive behavior, particularly concerning patents. This could potentially intensify EU regulators’ scrutiny of Edwards, Reuters reports. Recent regulatory actions in the United States and Europe aim to promote fair competition and maintain drug and product affordability, especially for smaller innovative companies challenging larger i
ZacksThe Zacks Analyst Blog Highlights Salesforce, BP, The Southern, PayPal and Edwards Lifesciences
Salesforce, BP, The Southern, PayPal and Edwards Lifesciences are included in this Analyst Blog.
ZacksTop Analyst Reports for Salesforce, BP & Southern Co.
Toda's Research Daily features new research reports on 16 major stocks, including Salesforce, Inc. (CRM), BP p.l.c. (BP) and The Southern Company (SO).
